These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33371777)

  • 41. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
    Dai J; Li ZX; Zhang Y; Ma JL; Zhou T; You WC; Li WQ; Pan KF
    Clin Transl Gastroenterol; 2019 Jan; 10(1):e00004. PubMed ID: 30702489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
    Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
    Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioinformatics analysis suggests that COL4A1 may play an important role in gastric carcinoma recurrence.
    Li F; Wang NN; Chang X; Wang SL; Wang LS; Yao J; Li ZS; Bai Y
    J Dig Dis; 2019 Aug; 20(8):391-400. PubMed ID: 31069993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
    Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
    Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    Liu J; Liu Z; Zhang X; Gong T; Yao D
    BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.
    Ren J; Xu S; Guo D; Zhang J; Liu S
    Clin Transl Oncol; 2014 Jul; 16(7):668-74. PubMed ID: 24248895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
    Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
    [No Abstract]   [Full Text] [Related]  

  • 51. THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
    Chen X; Huang Y; Wang Y; Wu Q; Hong S; Huang Z
    J Physiol Biochem; 2019 Feb; 75(1):117-123. PubMed ID: 30746617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
    Li Z; Guo Q; Lu Y; Tian T
    Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.
    Li L; Fu LQ; Wang HJ; Wang YY
    Pathol Oncol Res; 2020 Jan; 26(1):273-279. PubMed ID: 30047046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
    Liu AG; Zhong JC; Chen G; He RQ; He YQ; Ma J; Yang LH; Wu XJ; Huang JT; Li JJ; Mo WJ; Qin XG
    Int J Oncol; 2020 Jul; 57(1):122-138. PubMed ID: 32319600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
    Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
    Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
    Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
    Fei HJ; Chen SC; Zhang JY; Li SY; Zhang LL; Chen YY; Chang CX; Xu CM
    Int J Oncol; 2018 Mar; 52(3):955-966. PubMed ID: 29328368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and validation of PGLS as a metabolic target for early screening and prognostic monitoring of gastric cancer.
    Yuan X; Xiao Y; Luo Y; Wei C; Wang J; Huang J; Liao W; Song S; Jiang Z
    J Clin Lab Anal; 2022 Feb; 36(2):e24189. PubMed ID: 34953081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Expression of COL10A1 Is an Independent Predictive Poor Prognostic Biomarker and Associated with Immune Infiltration in Advanced Gastric Cancer Microenvironment.
    Shen N; Zhu S; Zhang Z; Yong X
    J Oncol; 2022; 2022():1463316. PubMed ID: 36276283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis.
    Fang W; Cui H; Yu D; Chen Y; Wang J; Yu G
    Med Oncol; 2014 Jul; 31(7):15. PubMed ID: 24924473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.